Does OLMESARTAN Cause Therapy non-responder? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Therapy non-responder have been filed in association with OLMESARTAN. This represents 0.7% of all adverse event reports for OLMESARTAN.
16
Reports of Therapy non-responder with OLMESARTAN
0.7%
of all OLMESARTAN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapy non-responder From OLMESARTAN?
Of the 16 reports, 2 (12.5%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN Cause?
Sprue-like enteropathy (391)
Diarrhoea (313)
Gastrointestinal disorder (276)
Acute kidney injury (209)
Weight decreased (197)
Hypotension (176)
Drug ineffective (131)
Dizziness (115)
Hypokalaemia (110)
Dyspnoea (106)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which OLMESARTAN Alternatives Have Lower Therapy non-responder Risk?
OLMESARTAN vs OLMESARTAN MEDOXOMIL
OLMESARTAN vs OLMETEC
OLMESARTAN vs OLODATEROL
OLMESARTAN vs OLODATEROL\TIOTROPIUM
OLMESARTAN vs OLOPATADINE